Cargando…

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis

Purpose: Cancer is a leading cause of morbidity and mortality worldwide. Off-label (OL) use of antineoplastic drugs to treat malignancies is prevalent. In this study, we quantified and characterized OL use of antineoplastic drugs to treat malignancies in China. Methods: This was a retrospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Guoxu, Wu, Min, Zhu, He, Han, Sheng, Chen, Jing, Zhai, Chenchen, Shi, Luwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060556/ https://www.ncbi.nlm.nih.gov/pubmed/33897416 http://dx.doi.org/10.3389/fphar.2021.616453

Ejemplares similares

Development of the First Value Assessment Index System for Off-Label Use of Antineoplastic Agents in China: A Delphi Study
por: Jiang, Qian, et al.
Publicado: (2020)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting
por: Herrero Fernandez, Marta, et al.
Publicado: (2019)

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022)

Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020)

Assesment of Adulterated Traditional Chinese Medicines in China: 2003-2017
por: Xu, Mingzhe, et al.
Publicado: (2019)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

Antineoplastics/ciclesonide/favipiravir: Pancytopenia and off-label use: case report
Publicado: (2022)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Impact of house price growth on mental health: Evidence from China
por: Wei, Guoxu, et al.
Publicado: (2020)

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
por: Vitale, Antonio, et al.
Publicado: (2016)

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
por: Fischler, Pascal Valentin, et al.
Publicado: (2022)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
por: Pesiou, Stella, et al.
Publicado: (2023)

Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis
por: Wu, Min, et al.
Publicado: (2015)

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease
por: Li, Xiao, et al.
Publicado: (2023)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020)

Antineoplastics/antiretrovirals: COVID-19, and diarrhoea due to off-label use: 3 case reports
Publicado: (2020)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
por: Agrawal, Samir, et al.
Publicado: (2019)

The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
por: Zhang, Zhiyu, et al.
Publicado: (2023)

Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
por: Wang, Yan, et al.
Publicado: (2023)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)
Publicado: (2023)

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil
por: dos Santos, Ranailla Lima Bandeira, et al.
Publicado: (2023)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
por: Tran, Thien B., et al.
Publicado: (2018)

The Public Health Insurance Coverage of Novel Targeted Anticancer Medicines in China—In Favor of Whom? A Retrospective Analysis of the Insurance Claim Data
por: Li, Mingshuang, et al.
Publicado: (2021)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

Antineoplastic prescription among patients with colorectal cancer in eight major cities of China, 2015–2019: an observational retrospective database analysis
por: Yao, Difei, et al.
Publicado: (2021)

Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study
por: Wang, Haitao, et al.
Publicado: (2022)

Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System
por: Gordon, Noa, et al.
Publicado: (2021)

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China
por: Huang, Tao, et al.
Publicado: (2022)

Trends in the utilization of psychotropic medications in China from 2018 to 2021
por: Zhang, Xinyan, et al.
Publicado: (2022)

An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors
por: Temre, Mithlesh Kumar, et al.
Publicado: (2022)

Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market
por: Shih, Ya-Chen Tina, et al.
Publicado: (2021)

Clinical and Economic Evaluation of Salvianolate Injection for Coronary Heart Disease: A Retrospective Study Based on National Health Insurance Data in China
por: Yang, Lisong, et al.
Publicado: (2020)

Botanical drugs for treating erectile dysfunction: clinical evidence
por: Xu, Dengjianyi, et al.
Publicado: (2023)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sinhgnacclap3r7n6hslhlv620